News & Events
Long-term efficacy, safety and tolerability of fingolimod
Fingolimod is effective in reducing relapses and brain volume loss
Improving fatigue by doing exercise
New evidence that exercise could reduce patients’ blood interferon level and fatigue
An appropriate way of measuring progression in clinical trials
Change in T25FW is strongly correlated with disease impact
Steroids, mobility and osteoporosis
The benefits of steroid therapy outweigh its detrimental effect on bone metabolism
Canada trial for stem cell therapy
The Mesenchymal Stem Cell Therapy for Canadian MS Patients Study is part of a larger international research…
Services and celebration in India
The MS Society of India recently organised two high-profile events
World MS Day launches on 15 April
People can share a thank-you message by email, by post or on social media
Spanish professionals trained in emotional health
The main aim was to share knowledge about emotions and stress and their effect on health
Biomarkers of spinal cord injury
Blood neurofilament concentrations could be used to quantify the severity of spinal cord lesions in MS
Future MS treatments
Ethyl pyruvate and dimethyl fumarate both have a number of anti-inflammatory effects relevant to MS
Cervical cord damage and disability in MS
Cord lesion load and spinal cord atrophy may contribute to disability in people with progressive MS
Infections and MS: new evidence
Study finds helicobacter pylori infection is associated with a reduction of risk of MS in women